Description
Darsil (Silymarin) Coated Tablets 22.5 mg. №50
Ingredients
Each coated tablet contains 22.5 mg of silymarin.
Mechanism of Action
Silymarin, the active component of Darsil tablets, exhibits hepatoprotective effects by acting as an antioxidant, anti-inflammatory agent, and promoting liver cell regeneration.
Pharmacological Properties
The pharmacological properties of silymarin include antioxidant activity, anti-inflammatory effects, and support for liver cell regeneration, contributing to its efficacy in managing liver disorders.
Indications for Use
Darsil tablets are indicated for the treatment of liver disorders such as hepatitis, cirrhosis, and fatty liver disease. The hepatoprotective properties of silymarin make it a valuable therapeutic option for liver health.
Contraindications
Avoid using Darsil tablets if you have a known allergy to silymarin or any other components of the product. Consult your healthcare provider for suitable alternatives.
Side Effects
Common side effects of Darsil tablets may include gastrointestinal disturbances such as mild stomach upset. If you experience any adverse reactions, discontinue use and seek medical advice.
Usage Instructions
The recommended dosage of Darsil tablets is one tablet orally three times a day. Follow the instructions provided by your healthcare professional and do not exceed the prescribed dose.
Benefits Compared to Analogues
Darsil tablets offer the advantage of standardized silymarin content and advanced coating technology for enhanced bioavailability. Compared to other liver support products, Darsil provides consistent dosing and optimal absorption.
Suitable Patient Groups
Darsil tablets are suitable for adult patients seeking liver support and management of liver disorders. Consult a healthcare provider for appropriate dosing in special populations such as children, pregnant women, and the elderly.
Storage and Shelf Life
Store Darsil tablets in a cool, dry place away from direct sunlight. Follow the storage instructions on the packaging and check the expiration date to ensure product efficacy.
Packaging Description
Darsil tablets are available in a package containing 50 coated tablets, each providing 22.5 mg of silymarin. The packaging is designed to maintain product integrity and protect the tablets from environmental factors.
Clinical Evidence and Proven Effectiveness
Silymarin, the key component of Darsil tablets, has demonstrated hepatoprotective effects in numerous clinical studies. Research supports the antioxidant, anti-inflammatory, and liver-regenerating properties of silymarin, highlighting its efficacy in managing various liver conditions.
